LAWRENCE — The family of a man killed by Lawrence police last month says Carlos Trotter's death means his mother can't receive a needed kidney transplant.
"The family of Carlos Trotter suffered emotional distress as a result of the death," attorney Jeffrey Cardella said in a Nov. 2 tort claim notice. "Additionally, Shirley Trotter, the mother, was unable to receive a kidney transplant from her son due to his premature death."
A tort claim notice is the first step towards filing a civil suit against a public agency in Indiana.
Officers shot Trotter, 36, on Oct. 27 after police say he led them on a chase in a stolen vehicle, crashed and "produced a weapon" in the 3100 block of North Shadeland Avenue.
A Lawrence officer shot Trotter one time, police said. Police did not say what kind of weapon Trotter produced that day. The weapon was found in Trotter's vehicle, police said.
Lawrence Police Chief Gary Woodruff said his department is aware of the tort claim notice and is consulting attorneys.
"It would be inappropriate for us to offer further comment, pending the ongoing investigation and legal process," Woodruff said.
Woodruff has not identified the officer who shot Trotter. The officer was placed on administrative duty pending the outcome of police and internal investigations.
Contact WRTV reporter Vic Ryckaert at victor.ryckaert@wrtv.com or on Twitter: @vicryc.
-
Gun rights, sports bans, tariffs — key Supreme Court rulings on the horizon
From tariffs to gun rights to sports bans, the U.S. Supreme Court’s decisions this term could reshape interpretations of the Constitution on personal rights and presidential power.
Zedd returns to headline 2026 Indy 500 Snake Pit
Electronic superstar Zedd is coming back to Indianapolis Motor Speedway, set to headline the 2026 Indy 500 Coors Light Snake Pit.
Bill that could bring Chicago Bears to Indiana advances in House committee
The Chicago Bears moved closer to relocating to Indiana Thursday as a House committee unanimously passed legislation creating the framework to finance a new NFL stadium in Hammond.
FDA to drop two-study requirement for new drug approvals, aiming to speed access
The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs.
